Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease.
Mol Ther Methods Clin Dev
; 25: 520-532, 2022 Jun 09.
Article
in En
| MEDLINE
| ID: mdl-35662813
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Mol Ther Methods Clin Dev
Year:
2022
Document type:
Article